ASSIGNMENT AND ASSUMPTION AGREEMENT (CAMBRIDGE, MASSACHUSETTS)Assignment and Assumption Agreement • February 29th, 2012 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”), dated as of December 31, 2011, is made by and between ARIAD Corporation, a Delaware corporation (“Assignor”) and ARIAD Pharmaceuticals, Inc., a Delaware corporation (“Assignee”).
AMENDMENT NO. 7 TO CREDIT AGREEMENTCredit Agreement • February 29th, 2012 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
THIS AMENDMENT NO. 7 (this “Amendment”) dated as of December 28, 2011 to the CREDIT AGREEMENT (the “Credit Agreement”) dated March 12, 2003, as amended by the Amendment No. 1 to Credit Agreement dated December 31, 2003 and further amended by the Amendment No. 2 to Credit Agreement dated December 31, 2004, and further amended by the Amendment No. 3 to Credit Agreement dated March 26, 2008, and further amended by the Amendment No. 4 to Credit Agreement dated June 19, 2009, and further amended by the Amendment No. 5 to Credit Agreement dated December 14, 2009, and further amended by the Amendment No. 6 to Credit Agreement dated January 6, 2011 is by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation (hereinafter sometimes referred to as the “Borrower”) and RBS Citizens, National Association (the "Lender"). All capitalized terms not defined herein but defined in the Credit Agreement shall have the meanings given to such terms in the Credit Agreement.
